- Home
- Equipment
- australasia
- clinical linked data
Show results for
Refine by
Clinical Linked Data Equipment Supplied In Australasia
5 equipment items found
by:Injectsense, Inc. based inEmeryville, CALIFORNIA (USA)
The Injectsense system is designed to create a path from raw data to clinically actionable information through various layers of hardware, software, firmware, and analytics at different levels, all of which interact to provide high-value patient baselines, trends, or snapshots for dynamic disease markers. Physicians and clinical teams can expect to use the system out of the box with standard ...
Manufactured by:Alma Lasers International based inNürnberg, GERMANY
A breakthrough hair removal platform that combines ultimate functionality with unparalleled comfort. Thanks to its large 4 cm2 spot size and advanced cooling system, treatments are now much faster and pain free – offering a significant improved solution for patients and practitioners alike. Soprano Titanium leverages the benefits of three combined wavelengths, with an improved patient ...
Manufactured by:Anatomics Pty Ltd. based inMelbourne, AUSTRALIA
BioModels are an anatomical model derived from the patient's CT scan data to provide tactile representation of the patient’s anatomy and condition. BioModels may assist with diagnosis informed consent, and precise planning of the sequence of surgery. BioModels may be used to plan incisions and osteotomies and can be sterilised and used as an intra-operative navigation tool. Clinical data ...
Manufactured by:Visionflex Pty Limited based inWarriewood, AUSTRALIA
The solution for fieldwork, outreach clinics and traveling health professionals - the ProEX Mobile Imaging System. Connecting patients to healthcare has never been easier with the ProEX Mobile Imaging System. The ruggedised, state-of-the-art tablet can be used in any situation and features a dual hot-swappable battery design, super bright touch screen display, water resistant (IP54) and shock ...
Manufactured by:Mesoblast Ltd. based inMelbourne, AUSTRALIA
Revascor is a Phase 3 product candidate being developed as a treatment for both advanced and end-stage chronic heart failure ...